Exendin(9-39)amide

Exendin-9-39 amide · Ludwig-Maximilians-Universität München

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Exendin(9-39)amide, covering 2011-10-04 to 2011-10-04. Get the full timeline:

Most recent: Clinical Trial Update: Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans [Phase 1]